President Trump on Thursday announced new agreements with pharmaceutical companies Eli Lilly and Novo Nordisk to lower the prices of several of their popular weight-loss drugs, including Wegovy and Zepbound. “The two world’s largest pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, have agreed to offer their most popular GLP-1 weight-loss drug — I call it the fat drug, remember — at drastic discounts,” the president said in the Oval Office, flanked by the pharmaceutical executives. Under